B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection.

Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med (2005) 2.03

The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med (2002) 1.59

CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J Immunol (2008) 1.19

Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J Virol (2007) 1.09

CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc Natl Acad Sci U S A (2009) 1.04

Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. PLoS Pathog (2014) 0.87

Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins. J Virol (2004) 0.78

Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice. PLoS One (2014) 0.78

Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle. J Virol (2003) 0.75

Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J Mol Biol (1975) 6.84

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med (1999) 6.27

T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04

Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol (1980) 3.95

Demonstration of globin messenger sequences in giant nuclear precursors of messenger RNA of avian erythroblasts. Proc Natl Acad Sci U S A (1973) 3.88

A molecular basis for MHC class II--associated autoimmunity. Science (1988) 3.75

Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol Cell Biol (1984) 3.15

The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci U S A (1987) 2.77

The region of mouse mammary tumor virus DNA containing the long terminal repeat includes a long coding sequence and signals for hormonally regulated transcription. EMBO J (1982) 2.76

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60

Synthesis of avian RNA tumor virus structural proteins. Cold Spring Harb Symp Quant Biol (1975) 2.55

Cloned mouse mammary tumor virus DNA is biologically active in transfected mouse cells and its expression is stimulated by glucocorticoid hormones. Cell (1981) 2.54

IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity (1997) 2.54

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut (2007) 2.49

Neuroprotection by estradiol. Prog Neurobiol (2001) 2.32

Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A (1990) 2.13

Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region. EMBO J (1983) 2.12

Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell (1993) 2.11

Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood (1999) 2.09

T cell recognition as the target for immune intervention in autoimmune disease. Cell (1989) 2.04

Origin and differentiation of dendritic cells. Trends Immunol (2001) 2.04

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med (2000) 1.99

T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med (1988) 1.89

Defective cleavage of a precursor polypeptide in a temperature-sensitive mutant of avian sarcoma virus. Virology (1976) 1.82

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med (1996) 1.80

Characterization of endogenous and exogenous mouse mammary tumor virus proviral DNA with site-specific molecular clones. J Virol (1980) 1.80

Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis (2008) 1.77

Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proc Natl Acad Sci U S A (1988) 1.75

Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells. Nature (1985) 1.74

DNA typing from skeletal remains: evaluation of multiplex and megaplex STR systems on DNA isolated from bone and teeth samples. Croat Med J (2001) 1.74

Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med (1993) 1.67

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today (1989) 1.66

RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars. Yeast (1989) 1.66

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol (2009) 1.63

Functional analysis of the glucocorticoid regulatory elements present in the mouse mammary tumor virus long terminal repeat. A synthetic distal binding site can replace the proximal binding domain. J Mol Biol (1986) 1.60

Isolation of poly(adenylic acid)-rich ribonucleic acid from mouse myeloma and synthesis of complementary deoxyribonucleic acid. Biochemistry (1973) 1.58

Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57

Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur J Immunol (1985) 1.52

CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity (2002) 1.49

The generation of the two envelope glycoproteins of Rous sarcoma virus from a common precursor polypeptide. Virology (1978) 1.49

Mutation rates at Y chromosome specific microsatellites. Hum Mutat (2005) 1.48

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging (2004) 1.47

An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45

Nucleotide sequence of the 5' noncoding region and part of the gag gene of mouse mammary tumor virus; identification of the 5' splicing site for subgenomic mRNAs. Nucleic Acids Res (1983) 1.45

Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs. Blood (2001) 1.42

Estimation of the number of genes coding for the constant part of the mouse immunoglobulin kappa light chain. Proc Natl Acad Sci U S A (1974) 1.42

A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas. EMBO J (1986) 1.39

Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol (2001) 1.38

Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2008) 1.37

Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J Virol (1988) 1.33

Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med (2001) 1.32

A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain. J Exp Med (1990) 1.31

Isolation and analysis of genomic DNA clones encoding the third component of mouse complement. Proc Natl Acad Sci U S A (1982) 1.30

Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med (1993) 1.29

Mouse mammary tumor virus: immunological interplays between virus and host. Adv Immunol (1997) 1.29

Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat. J Virol (1986) 1.28

Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J Exp Med (1994) 1.28

Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med (2000) 1.26

Identification of mouse mammary tumor virus-specific mRNA. J Virol (1979) 1.25

FGF2 plays a key role in embryonic cerebrospinal fluid trophic properties over chick embryo neuroepithelial stem cells. Dev Biol (2006) 1.23

Glucose transport in the yeast Kluyveromyces lactis. I. Properties of an inducible low-affinity glucose transporter gene. Mol Gen Genet (1992) 1.22

Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene (1996) 1.22

Sequence determination of the 3' end of mouse mammary tumor virus RNA. Mol Biol Rep (1981) 1.21

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur J Immunol (2001) 1.21

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther (2000) 1.20

Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience (1999) 1.20

Isolation of the DLD gene of Saccharomyces cerevisiae encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. Mol Gen Genet (1993) 1.19

Characterization of cloned cytotoxic lymphocytes with NK-like activity. J Immunol (1983) 1.18

Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol (1999) 1.16

Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev (2001) 1.15

Rifampicin inhibits focus formation in chick fibroblasts infected with Rous sarcoma virus. Nature (1969) 1.15

Genomic location of mouse mammary tumor virus proviral DNA in normal mouse tissue and in mammary tumors. Cold Spring Harb Symp Quant Biol (1980) 1.14

Extracellular cleavage of the glycoprotein precursor of Rous sarcoma virus. J Virol (1979) 1.14

Aromatase expression in the human temporal cortex. Neuroscience (2006) 1.14

Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3alpha. FEBS Lett (1998) 1.12

Biosynthesis of an unglycosylated envelope glycoprotein of Rous sarcoma virus in the presence of tunicamycin. J Virol (1979) 1.12

Synthesis of the precursor to avian RNA tumor virus internal structural proteins early after infection. Virology (1976) 1.11

A new ambulatory system for comparative evaluation of the three-dimensional knee kinematics, applied to anterior cruciate ligament injuries. Knee Surg Sports Traumatol Arthrosc (2006) 1.11

Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J Neuroendocrinol (2004) 1.10

Mouse complement components C3 and C4. Characterization of their messenger RNA and molecular cloning of complementary DNA for C3. J Biol Chem (1981) 1.10

Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J Exp Med (1994) 1.09

Transcription of the bacteriophage T4 template. Obligate synthesis of T4 prereplicative RNA in vitro. Biochemistry (1970) 1.08

Structural analysis of TCR-ligand interactions studied on H-2Kd-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity (1995) 1.07

Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Arch Virol (2003) 1.06

Tissue-specific segregation of TCRgamma delta+ NKT cells according to phenotype TCR repertoire and activation status: parallels with TCR alphabeta+NKT cells. Eur J Immunol (2001) 1.05

Murine leukemia virus proteins expressed on the surface of infected cells in culture. J Virol (1980) 1.05

Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. J Immunol (1997) 1.04

Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) (1990) 1.04

Dual function of a nuclear factor I binding site in MMTV transcription regulation. Nucleic Acids Res (1989) 1.04

Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04

In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection. BMC Microbiol (2001) 1.03

Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience (2005) 1.02

Cloned endogenous mouse mammary tumor virus DNA is biologically active in transfected mouse cells and its expression is stimulated by glucocorticoid hormones. Virology (1982) 1.02